Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

2012; Elsevier BV; Volume: 12; Issue: 7 Linguagem: Inglês

10.1016/s1473-3099(12)70088-9

ISSN

1474-4457

Autores

Merlin L. Robb, Supachai Rerks‐Ngarm, Sorachai Nitayaphan, Punnee Pitisuttithum, Jaranit Kaewkungwal, Prayura Kunasol, Chirasak Khamboonruang, P Thongcharoen, Patricia Morgan, Michael W. Benenson, Robert Paris, Joseph Chiu, Elizabeth M. Adams, Donald P. Francis, Sanjay Gurunathan, Jim Tartaglia, Peter B. Gilbert, Don Stablein, Nelson L. Michael, Jérôme H. Kim,

Tópico(s)

Hepatitis C virus research

Referência(s)